BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181228
DTEND;VALUE=DATE:20190130
DTSTAMP:20260730T002336
CREATED:20181228T155651Z
LAST-MODIFIED:20181228T160742Z
UID:20967-1545955200-1548806399@ces.b2sg.org
SUMMARY:Post Doctoral Fellow
DESCRIPTION:NIH funded postdoctoral positions are immediately available in the laboratory of Dr. Zhao at the Hospital for Special Surgery affiliated to Weill Medical College of Cornell University in the New York City. \n\nOngoing studies include identification of novel players and regulatory mechanisms of osteoclast differentiation\, osteoblast differentiation and bone remodeling in the physiological and pathological settings in osteoimmunology field\, an exciting interdisciplinary research field linking bone biology and immune system. We apply cutting edge cellular and molecular techniques including RNAseq and ChIPseq and use various genetic and disease mouse models to accomplish the study. Relevant publications: Nature Medicine\, 15 (9):1066-71\, 2009; Journal of Experimental Medicine\, 209(2):319-34\, 2012; Journal of Clinical Investigation\, 124 (11):5057-73\, 2014. \n\nWe are recruiting postdoctoral candidates who have a recent Ph.D. and strong research interest and expertise in cell biology/signaling\, cell differentiation and development\, immunology\, metabolisms or epigenetics.  Candidates with experience in osteoclast\, osteoblast\, chondrocyte or adipocyte differentiation are preferred. Qualified candidate must have a record of peer reviewed publications and experience working with genetic mutant mice and disease models.  Familiarity with microarray or sequence analysis is highly preferred. High level of motivation\, critical thinking and strong troubleshooting ability are expected. Effective communication in English is required. PhD candidates expected graduations are highly encouraged to apply. \nCompetitive salary and an excellent benefits package (Medical\, Dental and Life insurances) are available and will commensurate with experience and accomplishments. \n\nFull applications including curriculum vitae\, a brief summary of past\, current and future research interests and accomplishments (1-2 paragraphs)\, selected reprints of publications\, three references and expected availability date should be submitted via email to: \n\nBaohong Zhao\, DMD\, PhD\nAssistant Professor \nDepartment of Medicine\nWeill Medical College of Cornell University \nAssistant Scientist\nArthritis and Tissue Degeneration Program
URL:https://ces.b2sg.org/event/hss-28dec18/
LOCATION:Hospital for Special Surgery\, New York City\, NY\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/05/HSS-hospital-for-special-surgery.jpg
END:VEVENT
END:VCALENDAR